N-Nitroso-N-Methylurea (MNU) CAS 684-93-5 Puritas >99.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of N-Nitroso-N-Methylurea (NMU) (CAS: 684-93-5) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com
Nomen chemicum | N-Nitroso-N-Methylurea |
Synonyma | MNU;N-Methyl-N-Nitrosourea;1-Methyl-1-Nitrosourea |
CAS Number | 684-93-5 |
CATTUS Number | RF-PI2256 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C2H5N3O2 |
M. Pondus | 103.08 |
Liquescens punctum | 119.0~ 124.0℃ |
Ferveret | 164.3℃ ad 760 mmHg |
Density | 1.46 g/cm3 |
Sensitiva | Humor Sensitivus, Sensitivus, Calor Sensitivus |
Repono Nativ. | Sub Inert Gas (Nitrogenium seu Argon) ad II ~ VIII "pro verbo brevis |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Off-White ut pallide Yellow udo solidus |
Puritas / Analysis Methodus | >99.0% (HPLC) |
13C NMR Imaginum | Conformat ut Structure |
Proton NMR Spectrum | Conformat ut Structure |
Stabilizer | Acidum sulphuricum continet sicut Stabilizer |
Test Standard | Enterprise Standard |
Consuetudinem | Pharmaceutical intermedia |
sarcina: Fluorinated Utrem, 25kg/Cardboard Drum, vel secundum exigentiam mos
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
N-Nitroso-N-Methylurea (MNU) (CAS: 684-93-5) est nitrosourea methylata composita cum alkylato, mutagenico, teratogenico, carcinogenico, et cytotoxicis proprietatibus.Effectus toxici MNU causantur translatione coetus yl nucleobases in acida nucleica.Praecursor Diazomethane.MNU materia diazomethane generationis est principium.Diazomethane derivationes yl cum acida carboxylicis et phenolis praebet in reactione admodum leni et leni.MNU est agens directum alkylatentem quod cum DNA correspondet, ut varietates reactionis productorum cedat.MNU pro intermediis pharmaceuticis adhibetur.